Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Pfizer reported strong 2024 profits Wednesday on the same day the Connecticut Attorney General’s office released a statement ...

Pfizer Inc. (NYSE:PFE – Get Free Report) shares traded up 2.9% on Wednesday following a stronger than expected earnings ...

A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

The Illinois Labor Relations Board has twice ruled that the city violated employees' collective bargaining rights by failing ...

Health-care companies rose after strong earnings from one major drug maker. Novo Nordisk shares rose sharply after the Danish obesity-drug maker posted fourth-quarter Ozempic sales of $4.71 billion, ...

I pine for the good old days of man flu, where the slightest symptom, a cough, a sniffle or a general sense of malaise, could ...

Dividend stocks are increasingly appealing for investors in 2025 due to their potential for steady income and resilience in volatile markets. As the economic landscape evolves, characterized by rising ...

Russell Broadbent and a group comprising scientists, health professionals, lawyers, and academics, wrote to the Prime ...

Now that the year is underway and a new presidential administration is in place in Washington, let’s consider the environment ...

Artificial intelligence is already helping businesses to increase operational efficiency and enhance customer experiences.

Moderna stock tumbled after the Senate Finance Committee voted to send RFK Jr.'s nomination for the HHS secretary to the full ...